Real-life experience of ranibizumab for diabetic macular edema in Taiwan

被引：0
作者：
Meng-Ju Tsai
Yi-Ting Hsieh
Yi-Jie Peng
机构：
[1] Buddhist Tzu Chi Medical Foundation,Department of Ophthalmology, Taipei Tzu Chi Hospital
[2] National Taiwan University Hospital,Department of Ophthalmology
来源：
International Ophthalmology | 2019年 / 39卷
关键词：
Diabetic macular edema; Intravitreal injections; Ranibizumab; Best-corrected visual acuity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1511 / 1522
页数：11
相关论文
共 50 条
  • [21] Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
    Ozkaya, Abdullah
    Alagoz, Cengiz
    Alagoz, Nese
    Gunes, Hasan
    Yilmaz, Ihsan
    Perente, Irfan
    Yazici, Ahmet T.
    Taskapili, Muhittin
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : 351 - 355
  • [22] Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany
    Ziemssen, Focke
    Wachtlin, Joachim
    Kuehlewein, Laura
    Gamulescu, Maria-Andreea
    Bertelmann, Thomas
    Feucht, Nikolaus
    Voegeler, Jessica
    Koch, Mirja
    Liakopoulos, Sandra
    Schmitz-Valckenberg, Steffen
    Spital, Georg
    DIABETES THERAPY, 2018, 9 (06) : 2271 - 2289
  • [23] Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
    Van Aken, Elisabeth
    Favreau, Meredis
    Ramboer, Eva
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    Brie, Heidi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 4173 - 4185
  • [24] Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany
    Focke Ziemssen
    Joachim Wachtlin
    Laura Kuehlewein
    Maria-Andreea Gamulescu
    Thomas Bertelmann
    Nikolaus Feucht
    Jessica Voegeler
    Mirja Koch
    Sandra Liakopoulos
    Steffen Schmitz-Valckenberg
    Georg Spital
    Diabetes Therapy, 2018, 9 : 2271 - 2289
  • [25] Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting
    Tsapardoni, F. N.
    Makri, O. E.
    Lagogiannis, A. P.
    Tsekouras, I. K.
    Chairas, N.
    Pallikari, A.
    Pagoulatos, D. D.
    Georgakopoulos, C. D.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2019, 22 : 47 - 54
  • [26] The effects of epiretinal membranes on the treatment outcomes of intravitreal aflibercept injection in diabetic macular edema: a real-life study
    Kocak Altintas, Ayse Gul
    Ilhan, Cagri
    Cankurtaran, Mahmut
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (10) : 2635 - 2641
  • [27] Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study
    Chatziralli, Irini
    Agapitou, Chrysa
    Dimitriou, Eleni
    Kapsis, Petros
    Kazantzis, Dimitrios
    Machairoudia, Genovefa
    Georgiadis, Odysseas
    Theodossiadis, George
    Theodossiadis, Panagiotis
    SEMINARS IN OPHTHALMOLOGY, 2024, 39 (01) : 96 - 101
  • [28] Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study
    Puren Isik
    Selcuk Sizmaz
    Ebru Esen
    Anıl Uysal
    Nihal Demircan
    International Ophthalmology, 2023, 43 : 4171 - 4180
  • [29] Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study
    Isik, Puren
    Sizmaz, Selcuk
    Esen, Ebru
    Uysal, Anil
    Demircan, Nihal
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (11) : 4171 - 4180
  • [30] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
    Maris, Dimitrios
    Dastiridou, Anna
    Kotoula, Maria
    Karathanou, Aikaterini
    Tsironi, Evangelia E.
    Bargiota, Alexandra
    Androudi, Sofia
    DIAGNOSTICS, 2024, 14 (12)
12345